Quinapril treatment enhances vascular sensitivity to insulin

Journal of Hypertension

Volumn 19, Issue 1, 2001, Pages 113-118

  Feldman, Ross D ^a,b   Schmidt, Nancy D ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b LONDON HEALTH SCIENCES CENTRE   (Canada)

Author keywords

Alpha adrenergic; Angiotensin converting enzyme inhibitors; Beta adrenergic; Hypertension; Insulin

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLUCOSE; INSULIN; PLACEBO; QUINAPRIL;

ADULT; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD VESSEL REACTIVITY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; GLUCOSE BLOOD LEVEL; HEMODYNAMICS; HUMAN; HYPERTENSION; INSULIN BLOOD LEVEL; INSULIN SENSITIVITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SODIUM RESTRICTION; VASODILATATION;

EID: 0035140216     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-200101000-00015     Document Type: Article

References (30)

1. Insulin resistance in essential hypertension
2. The vasodilator action of insulin: Implications for the insulin hypothesis of hypertension
3. Insulin-mediated vasodilation: Impairment with increased blood pressure and body mass
4. Beta adrenergic-mediated vasodilator response to insulin in the human forearm
5. Decreased effect of insulin to stimulate skeletal muscle blood flow in obese man: A novel mechanism for insulin resistance
6. Skeletal muscle blood flow: A possible link between insulin resistance and blood pressure
7. Insulin-stimulated production of nitric oxide is inhibited by wortmannin. Direct measurement in vascular endothelial cells
8. Insulin-mediated skeletal muscle vasodilation is nitric oxide dependent. A novel action of insulin to increase nitric oxide release
9. Dietary salt restriction increases vascular insulin resistance
10. Moderate dietary salt restriction increases vascular and systemic insulin resistance
11. Improvement of insulin sensitivity contributes to blood pressure reduction after weight loss in hypertensive subjects with obesity
12. Obesity and insulin resistance: A dose-response study
13. Pharmacologic therapy for Type 2 diabetes mellitus
14. ACE inhibition but not angiotensin II antagonism reduces plasma fibrinogen and insulin resistance in overweight hypertensive patients
15. Comparative effects of lisinopril and losartan on insulin sensitivity in the treatment of non diabetic hypertensive patients
16. Regression of left ventricular wall thickness during ACE-inhibitor treatment of essential hypertension is associated with an increase in insulin mediated skeletal muscle blood flow
17. Differential effects of quinaprilat and enalaprilat on endothelial function of conduit arteries in patients with chronic heart failure
18. Improvement in endothelial function by angiotensin-converting enzyme inhibition in non-insulin-dependent diabetes mellitus
19. Angiotensin-converting enzyme inhibition improves venous endothelial dysfunction in chronic smokers
20. Long-term use of angiotensin-converting enzyme inhibitors to modify endothelial dysfunction: A review of clinical investigations
21. Impaired vasodilator function in hypertension: The role of alterations in receptor/G-protein coupling
22. Defective venous beta-adrenergic response in borderline hypertensive subjects is corrected by a low sodium diet
23. Low sodium intake corrects abnormality in beta-receptor-mediated arterial vasodilation in patients with hypertension: Correlation with beta-receptor function in vitro
24. Beta-adrenergic responsiveness is regulated selectively in hypertension
25. Determination of free and total insulin and C-peptide in insulin-treated diabetics
26. Direct angiotensin converting enzyme inhibitor-mediated venodilation
27. Effects of losartan on insulin sensitivity in hypertensive subjects
28. Human insulin-mediated enhancement of vascular β-adrenergic responsiveness
29. Insulin-mediated sensitization of adenylyl cyclase activation